kentucky glp-1 stomach paralysis law firm digestive blockage office gastroparesis in GLP-1 medications are now at the center of kentucky semaglutide law – kentucky glp-1 nausea legal team

The following milestones mark important progress in the consolidated federal litigation: Increased evidentiary standards for gastroparesis claims: Courts require plaintiffs alleging gastroparesis to support claims with objective gastric-emptying tests rather than symptoms alone, raising the bar for admissible medical evidence Daubert hearings on expert testimony: May 2025 hearings will determine whether plaintiffs medical experts can testify about causation potentially decisive rulings that could strengthen or weaken thousands of claims Short-form complaint process adoption: MDL implemented streamlined filing procedures to manage the influx of new cases efficiently while maintaining procedural fairness Monthly status conferences throughout 2025: Regular court meetings ensure ongoing case management and coordination as parties work through challenging scientific and legal issues In September 2025, Judge Marston allowed most plaintiffs claims to proceed after denying defendants motions to dismiss, including accusations that drugmakers failed to warn about gastrointestinal issues and misrepresented safety

It specifically calls for glucose monitoring in people with diabetes and renal-function monitoring when gastrointestinal reactions may cause volume depletion

This is the same receptor system that slows gastric emptying to create satiety

Think of L-citrulline as a slow-release form of L-arginine

reported that 2% of EGD procedures were aborted due to RGC among patients on GLP-1 RAs